Prospective Evaluation of Speech Function Through Patient- and Parent-response Outcome Measurements in Velopharyngeal Insufficiency

Sponsor
Umeå University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05838261
Collaborator
Karolinska University Hospital (Other), Uppsala University Hospital (Other), University Hospital, Linkoeping (Other), Skane University Hospital (Other), Sahlgrenska University Hospital, Sweden (Other)
50
6
40.3
8.3
0.2

Study Details

Study Description

Brief Summary

Cleft lip and/or palate (CL/P) is the most common congenital malformation, with about one in 500 children born with CL/P in Sweden, corresponding to approximately 175 births annually. Depending on the extent of the cleft palate, the degree of functional loss varies, but both eating, hearing, speech, bite and appearance can be affected.

Patients treated for isolated or combined cleft palate may suffer from velopharyngeal insufficiency (VPI), which means difficulties in closing the passage between the oral and nasal cavities during speech. Velopharyngeal insufficiency is associated with hypernasality, audible nasal air leakage and weak articulation, which might lead to difficulties with communication and social stigmatization.

The most common form of speech-improving surgery is a posterior based velopharyngeal flap, creating a bridge between the palate and the posterior pharyngeal wall to more easily compensate for the abnormal airflow through the nose during speech. However, surgical management of VPI is challenging, with variable success rates reported in the literature. In a retrospectively based questionnaire study on patients who underwent surgical treatment of VPI, 30% experienced only a small speech improvement or no improvement at all. In addition, postoperative speech impairment have also been reported, as well as perioperative bleeding and postoperative sleep apnea. Thus, selecting the patients who benefit most from speech-improving surgery is therefore of great importance.

The aim with the current study is evaluation of speech function through patient- and parent-response outcome measurements following surgical treatment of velopharyngeal insufficiency in children with isolated or combined cleft palate.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pharyngeal flap

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Evaluation of Speech Function Through Patient- and Parent-response Outcome Measurements Following Surgical Treatment of Velopharyngeal Insufficiency in Children With Isolated or Combined Cleft Palate
Actual Study Start Date :
Aug 24, 2022
Anticipated Primary Completion Date :
Jan 1, 2026
Anticipated Study Completion Date :
Jan 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Children with cleft palate with velopharyngeal insufficiency undergoing surgical treatment

Children with combined or isolated cleft palate with velopharyngeal insufficiency undergoing surgical treatment with pharyngeal flap

Procedure: Pharyngeal flap
Children with combined or isolated cleft palate with velopharyngeal insufficiency undergoing surgical treatment with pharyngeal flap will be evaluated with patient- and parent reported outcome measures before and after the surgery.

Outcome Measures

Primary Outcome Measures

  1. Speech function [Change in speech function will be evaluated preoperatively and 1 year postoperatively]

    Speech function will be evaluated through the patient response outcome measurement CLEFT-Q pre- and postoperatively. Each CLEFT-Q scale is transformed into scores that range from 0-100, with higher scores reflecting a better outcome.

  2. Speech function [Change in speech function will be evaluated preoperatively and 1 year postoperatively.]

    Speech function will be evaluated through the parent-response outcome measurement Intelligibility in Context Scale pre- and postoperatively. The maximum and minimum value ranges from 0-35 respectively, with higher scores reflecting a better outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Years to 17 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • All children < 18 years of age with isolated or combined cleft palate that will undergo pharyngeal flap surgery due to velopharyngeal insufficiency, as well as their parents, in any of the 6 specialized cleft center in Sweden.
Exclusion Criteria:
  • Cognitive impairment making it difficult to understand the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sahlgrenska University Hospital Göteborg Sweden
2 Linköping University Hospital Linköping Sweden
3 Skånes University Hospital Malmö Sweden
4 Karolinska University Hospital Stockholm Sweden
5 Plastic Surgery Unit, Umeå University hospital Umeå Sweden
6 Uppsala University Hospital Uppsala Sweden

Sponsors and Collaborators

  • Umeå University
  • Karolinska University Hospital
  • Uppsala University Hospital
  • University Hospital, Linkoeping
  • Skane University Hospital
  • Sahlgrenska University Hospital, Sweden

Investigators

  • Principal Investigator: Rebecca Wiberg, MD PhD, Umeå University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rebecka Wiberg, Principal Investigator, Umeå University
ClinicalTrials.gov Identifier:
NCT05838261
Other Study ID Numbers:
  • 2023-VPI-RWiberg
First Posted:
May 1, 2023
Last Update Posted:
May 1, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rebecka Wiberg, Principal Investigator, Umeå University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 1, 2023